Dauch: Dowlais Gives More Ways To Grow

Impact · against what's priced in

Dauch Corporation (DCH) appears undervalued given the acceleration of cost synergies from the Dowlais acquisition and a low forward EBITDA multiple. The news provides a positive catalyst through early achievement of synergy targets and improved risk profiles via diversification.

DCH+0.60

No priced-in read yet

In context

The tracking of $300 million in cost synergies ahead of schedule and a valuation of 3.7x forward EBITDA suggest near-term margin expansion and an undervalued entry point.

Read from the article alone

• ebitda▲93%
• valuation
• DCH
• acquisition
• growth strategy
• margin expansion
• synergies

Top 1 mover · tap to explore